Stephen D. Roughley

2 ta ish

Granta Design (United Kingdom)

1. Combining Hit Identification Strategies: Fragment-Based and in Silico Approaches to Orally Active 2-Aminothieno[2,3-<i>d</i>]pyrimidine Inhibitors of the Hsp90 Molecular Chaperone

   Paul A. Brough, Xavier Barril, Jenifer Borgognoni +30

   Maqola20092 iqtibos

   ABIABI:AkademIndex/2026.other.035864

2. 4,5-Diarylisoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents for the Treatment of Cancer

   Paul A. Brough, Wynne Aherne, Xavier Barril +34

   Maqola20072 iqtibos

   ABIABI:AkademIndex/2026.other.529465